Latest Albert Sabin Stories
Successful Public-Private Partnerships Hope to Encourage Increased Private and Public Sector Participation BERLIN, Sept. 28, 2012 /PRNewswire-USNewswire/ -- Global health advocates and the pharmaceutical industry came together to discuss strategies for improved collaboration and increased private sector involvement in neglected tropical disease (NTD) treatment and control programs. During a workshop in Berlin, experts from the World Health Organization (WHO), the Bill & Melinda...
END7 campaign fights treatable Neglected Tropical Diseases (NTDs) that infect more than 1 billion people WASHINGTON, Aug. 1, 2012 /PRNewswire-USNewswire/ -- Celebrities from around the world called on their fans and followers to join the END7 campaign, a global effort to eliminate seven neglected tropical diseases (NTDs) by 2020. END7 is a campaign of the Sabin Vaccine Institute. Music, entertainment and fashion stars, including Katy Perry, Slash, Ewan McGregor, Stella McCartney,...
Symposium on Smallpox Eradication and the Future of Global Health Featured in a Special Edition of the journal Vaccine WASHINGTON, April 24, 2012 /PRNewswire-USNewswire/ -- In a special edition of Vaccine released today, Sabin President, Dr. Peter Hotez, and Sabin Executive Vice President, Dr. Ciro de Quadros, share their insights on global health innovations and advancements since the eradication of smallpox was certified by the World Health Assembly in 1980. Their commentary is...
"Harry Potter" star joins global effort to eliminate seven diseases by 2020 LONDON, April 12, 2012 /PRNewswire-USNewswire/ -- British actor Tom Felton is calling on his fans to join him in the fight to eliminate seven neglected tropical diseases (NTDs) by 2020. As an ambassador for the END7 campaign, Felton is helping to raise public awareness about these devastating diseases of poverty that infect one in six people worldwide, including 500 million children. (Photo:...
SEATTLE, Jan. 31, 2012 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) announced its technical support of the Sabin Vaccine Institute's (Sabin) first ever Phase 1 clinical trial of a human hookworm vaccine candidate, which began last week in Brazil. The trial is a very significant and a critical step toward developing a vaccine that would reduce the global burden of human hookworm by providing effective long-term protection for those who are most at risk....
The END7 Campaign is dedicated to building awareness of diseases that infect more than one billion people worldwide WASHINGTON, Jan. 10, 2012 /PRNewswire-USNewswire/ -- Launched today, the END7 campaign is dedicated to eliminating seven major neglected tropical diseases (NTDs) as a public health threat to poor communities by the end of 2020. NTDs infect one in six people worldwide, including 500 million children, and carry a higher health burden than malaria and...
WASHINGTON, July 14, 2011 /PRNewswire-USNewswire/ -- The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro, and Alisa Swidler to the organization's Board of Trustees. "We are honored to have such distinguished individuals join the Sabin Board," said Morton Hyman, Chairman of the Board of Trustees. "We appreciate their trust and confidence in the Institute and their commitment to our mission to treat and, where...
A debate published this week in PLoS Medicine examines new approaches to tackling neglected tropical diseases (NTDs), with three viewpoints from experts in the field arguing which approach shows most promise.Jerry Spiegel and colleagues from the University of British Columbia argue that there has been too much focus on biomedical mechanisms and drug development for NTDs, which has come at the expense of the social determinants of health such as clean water, sanitation, good housing, and...
Former diplomat takes reins of leading vaccine development and advocacy organization WASHINGTON, April 28 /PRNewswire-USNewswire/ -- Michael W. Marine, former U.S. Ambassador to the Socialist Republic of Vietnam, has been appointed as the new chief executive officer of the Sabin Vaccine Institute, announced Sabin's Chairman of the Board of Trustees Mort Hyman and President Dr. Peter Hotez. Ambassador Marine served 32 years in the U.S. State Department's Foreign Service and was a six time...
Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has announced that Russia has chosen the company's inactivated polio vaccine for primary immunization of all infants. The inactivated polio vaccine (IPV) doses are provided by MP Chumakov Institute of Poliomyelitis and Virus Encephalitides through a manufacturing agreement with Sanofi Pasteur. The Russian Federation was certified polio-free in 2002. Since 2006, children from certain at risk groups are vaccinated with IPV....
